Literature DB >> 2903767

Multiple species of myeloperoxidase messenger RNAs produced by alternative splicing and differential polyadenylation.

K Hashinaka1, C Nishio, S J Hur, F Sakiyama, S Tsunasawa, M Yamada.   

Abstract

Three clones of full-length cDNA encoding human myeloperoxidase were isolated from a human leukemia HL-60 cell cDNA library in lambda gt10 and characterized. Analysis of the nucleotide sequence of one of the cDNA clones, lambda MP-H17, indicated that the cDNA contained 3207 bp with an open reading frame of 2238 bp, a 5' noncoding region of 159 bp, a 3' noncoding region of 800 bp, and a poly(A) tail of 10 bp. cDNA of the two other clones, lambda MP-H7 and lambda MP-H14, each contained insertions with shorter sequences of 96 and 82 bp, respectively, on the open reading frame of lambda MP-H17 cDNA. A myeloperoxidase genomic clone was isolated, and the structure of its 5' region was determined and compared with the structures of these cDNAs. The comparison revealed that the three cDNAs were derived from myeloperoxidase mRNAs produced by alternative splicing from a transcript of the single gene. Nucleotide sequence analysis of the 3' region of the cDNAs of several clones indicated that the mRNAs were polyadenylated at five different sites. Amino acid sequence determination of the amino-terminal and carboxy-terminal portions of the myeloperoxidase light and heavy chains revealed that, during processing of a precursor polypeptide into the mature protein, the amino-terminal polypeptide, the small peptide between the light and heavy chains, and the carboxy-terminal amino acid were excised.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2903767     DOI: 10.1021/bi00416a013

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

Review 1.  Biosynthesis of human myeloperoxidase.

Authors:  William M Nauseef
Journal:  Arch Biochem Biophys       Date:  2018-02-03       Impact factor: 4.013

2.  Arginine to cysteine mutation (R499C) found in a Japanese patient with complete myeloperoxidase deficiency.

Authors:  Amanda S Persad; Yosuke Kameoka; Shuji Kanda; Yoshiyuki Niho; Kazuo Suzuki
Journal:  Gene Expr       Date:  2006

3.  IgM anti-myeloperoxidase antibody-secreting lymphocytes are present in the peripheral repertoire of lupus mice but rarely differentiate into IgG-producing cells.

Authors:  O Vittecoq; F Brard; F Jovelin; X Le Loet; F Tron; D Gilbert
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

4.  Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase.

Authors:  Y Aratani; H Koyama; S Nyui; K Suzuki; F Kura; N Maeda
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

5.  A panel set for epitope analysis of myeloperoxidase (MPO)-specific antineutrophil cytoplasmic antibody MPO-ANCA using recombinant hexamer histidine-tagged MPO deletion mutants.

Authors:  K Tomizawa; E Mine; A Fujii; Y Y Ohashi; S Yamagoe; Y Hashimoto; A Ishida-Okawara; M Ito; M Tanokura; T Yamamoto; Y Arimura; T Nagasawa; S Mizuno; K Suzuki
Journal:  J Clin Immunol       Date:  1998-03       Impact factor: 8.317

Review 6.  The Intestinal Redox System and Its Significance in Chemotherapy-Induced Intestinal Mucositis.

Authors:  Qing-Qing Yu; Heng Zhang; Yujin Guo; Baoqin Han; Pei Jiang
Journal:  Oxid Med Cell Longev       Date:  2022-05-09       Impact factor: 7.310

Review 7.  Myeloperoxidase: A new player in autoimmunity.

Authors:  Anna Strzepa; Kirkwood A Pritchard; Bonnie N Dittel
Journal:  Cell Immunol       Date:  2017-05-10       Impact factor: 4.868

Review 8.  B cell epitope specificity in ANCA-associated vasculitis: does it matter?

Authors:  Y M van der Geld; C A Stegeman; C G M Kallenberg
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

9.  Molecular heterogeneity and alternative splicing of human lactoperoxidase.

Authors:  Miryam A Fragoso; Aliza Torbati; Nevis Fregien; Gregory E Conner
Journal:  Arch Biochem Biophys       Date:  2008-11-24       Impact factor: 4.013

10.  Some patients with anti-myeloperoxidase autoantibodies have a C-ANCA pattern.

Authors:  M Segelmark; B Baslund; J Wieslander
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.